Drug Profile


Alternative Names: PCP-Scan

Latest Information Update: 22 Aug 2002

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Immunomedics
  • Class Fab fragments; Radiopharmaceutical diagnostics
  • Mechanism of Action Radionuclide imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Pneumocystis pneumonia

Most Recent Events

  • 22 Aug 2002 Discontinued - Phase-I for Pneumocystis pneumonia (diagnosis) in USA (unspecified route)
  • 31 Jan 2001 No development reported - Phase-I for Pneumocystis pneumonia (diagnosis) in USA (unspecified route)
  • 10 Feb 1998 Phase-I clinical trials for Pneumocystis pneumonia (diagnosis) in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top